Assertio Therapeutics Settles for $3.6 Million Over Alleged False Claims Act Violations Linked to Fentanyl Marketing
Assertio Therapeutics settled for $3.6 million over False Claims Act violations regarding the marketing of the fentanyl product Lazanda, which included targeting high-prescribing pain specialists.
Trinidad and Tobago Hosts TRADEWINDS 2025 Exercise, Bolstering International Fight Against Transnational Crime
Trinidad and Tobago hosted TRADEWINDS 2025 with over 1,000 participants to strengthen efforts against transnational crime, focusing on firearms trafficking. ICE HSI contributed significantly alongside local law enforcement.












